e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elevation Oncology Inc
(NQ:
ELEV
)
0.6700
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elevation Oncology Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
August 06, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?
August 06, 2024
Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate in patients with advanced solid tumors expressing Claudin 18.2. No Grade 4...
Via
Benzinga
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
August 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
August 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Elevation Oncology Q4 Earnings
March 06, 2024
Via
Benzinga
How Is The Market Feeling About Elevation Oncology?
January 31, 2024
Via
Benzinga
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
January 17, 2024
Via
AB Newswire
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
July 18, 2024
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.
Via
Benzinga
7 Top Stocks to Buy for Under $10: May 2024
May 27, 2024
By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024
May 02, 2024
ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 02, 2024
Via
Benzinga
7 Top Stocks Under $7
April 11, 2024
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now.
Via
InvestorPlace
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023
March 06, 2024
ELEV stock results show that Elevation Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
March 05, 2024
While these companies have seen a stratospheric rise in their market value, they’re now candidates for overbought stocks to sell.
Via
InvestorPlace
3 Stock Winners That Are Up 400% or More in 2024
February 23, 2024
Explore stocks winners of 2024, including MicroCloud, Beamr Imaging, and Elevation Oncology, each seeing 400% gains in a GenAI-led rally.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 12, 2024
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
January 10, 2024
Shares of Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance. The company said revenue will likely be impacted by an...
Via
Benzinga
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024
From
FN Media Group LLC
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 08, 2024
Via
Benzinga
What's Going On With Elevation Oncology Stock?
January 08, 2024
Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday.
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 05, 2024
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
